Site logo
Site logo

Key Capabilities: Drug Screening

Compound Libraries

All our compound libraries are based in Oxford. We currently have 20,000 proprietary compounds and growing, with access to numerous additional small molecules and natural products through varied research activities of Oxford's synthetic chemistry community.

Assay Development

NMR/Mass Spectrometry facilities for screening

Molecular Modelling

Virtual Libraries and Screening
Stacks Image 62
Target Discovery Institute

The Target Discovery Institute (TDI) is a major new collaborative research initiative. The Institute will investigate drug target discovery across various diseases drawing on the expertise of the research staff on the Campus, Medical Science Division and wider University capitalising on existing strengths in genetics and genomic medicine, molecular and cell biology, structural biology, chemistry, pharmacology and medicine. The centre aims to link recent advances in genetics, genomics and cell and chemical biology for improved drug target discovery. A more specific focus for refining and validating such targets will provide a better link between traditional "open ended" academic processes to biomedical research and the need of the pharmaceutical industry for accurately defined targets for drug development.

Important TDI links:
Mass Spectrometry for Target Discovery
Target Discovery in Drug Development
For further details of the Oxford Target Discovery Institute, including information on the high throughput screening facility, can be found at http://www.tdi.ox.ac.uk/home. For specific queries, please contact Dr Daniel Ebner, the Cell Screening Officer: debner@well.ox.ac.uk.